Source comparison
BPC-157 Comparative Studies — Comparison Table
The following table summarizes key findings from bpc-157 comparative studies across tissue repair, gastric protection, and angiogenesis outcomes. Each row represents a published head-to-head trial or mechanistic comparison. J. Physiology Pharmacology 2020 BPC
This comparison does not assign a generated winner or score.
- The following table summarizes key findings from bpc-157 comparative studies across tissue repair, gastric protection, and angiogenesis outcomes. Each row represents a published head-to-head trial or mechanistic comparison.
- J. Physiology Pharmacology 2020
- BPC-157 vs TB-500 (rat tendon)
- Tensile strength at day 28
- +62% vs control
- +38% vs control
- BPC-157 activates FAK signaling; TB-500 promotes cell migration
- Biomedicine Pharmacotherapy 2021
- BPC-157 vs collagen peptides (ligament)
- Vascular density at week 3
- 3.2× control
- 1.1× control
- BPC-157 upregulates VEGF; collagen provides amino acids only
- World J. Gastroenterology 2017
- BPC-157 vs TB-500 (gastric ulcer)
- Ulcer index reduction
- −72% vs control
- No significant change
- BPC-157 stabilizes mucosa; TB-500 has no gastric activity
- Nutrients 2021
- BPC-157 vs hydrolyzed collagen (rat ligament)
- Collagen fiber alignment
- +47% vs control
- +12% vs control
- BPC-157 organizes matrix via FAK; collagen increases raw deposition
- Regulatory Peptides 2018
- BPC-157 vs bFGF (diabetic wound)
- Healing rate in diabetic rats
- +41% vs diabetic control
- No significant effect
- BPC-157 functions despite receptor impairment in metabolic disease
- J. Biological Regulators 2020
- BPC-157 vs PRP (tendon)
- Late-stage remodeling (days 14–28)
- Superior tissue maturation
- Faster early healing (days 1–7)
- PRP delivers acute growth factor bolus; BPC-157 sustains angiogenesis